Showing results (11-20 of 219) with videos related to
Sort By:
Pageof 22
Leukemia|September 1, 1995
A 3-day schedule of fludarabine in previously treated chronic lymphocytic leukemiaL E Robertson, S O'Brien, H Kantarjian, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1994
Fludarabine--present status and future developments in chronic lymphocytic leukemia and lymphomaM J Keating, P McLaughlin, W Plunkett, et al.Journal of Clinical Psychology|January 1, 1984
Parents' treatment expectations and attrition from a child psychiatric serviceJ W PlunkettCurrent Opinion in Oncology|October 24, 2001
Design of new anticancer therapies targeting cell cycle checkpoint pathwaysD Sampath, W PlunkettMolecular Pharmacology|April 1, 1991
Action of 9-beta-D-arabinofuranosyl-2-fluoroadenine on RNA metabolismP Huang, W PlunkettBiochemical Pharmacology|September 15, 1987
Phosphorolytic cleavage of 2-fluoroadenine from 9-beta-D-arabinofuranosyl-2-fluoroadenine by Escherichia coli. A pathway for 2-fluoro-ATP productionP Huang, W PlunkettCancer Chemotherapy and Pharmacology|January 1, 1992
Cell cycle-specific metabolism of arabinosyl nucleosides in K562 human leukemia cellsV Gandhi, W PlunkettCancer Research|December 5, 2000
The role of c-Jun kinase in the apoptotic response to nucleoside analogue-induced DNA damageD Sampath, W PlunkettDrugs|January 1, 1994
Evolution of the arabinosides and the pharmacology of fludarabineW Plunkett, V GandhiCancer Chemotherapy and Pharmacology|January 1, 1995
Fludarabine- and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical eventP Huang, W PlunkettPageof 22